Recent News

Drugs and Biotech

• [09/03] Rochester Leads International Effort to Improve Muscular Dystrophy Treatment
• [09/03] Tibotec Pharmaceuticals Seeks European Marketing Authorization for Investigational Once-Daily HIV Treatment TMC278
• [09/02] American Society for Biochemistry and Molecular Biology Reacts to District Court Stem-Cell Ruling
• [09/02] Office of Justice Programs Weekly News Brief
• [09/02] Sequenom to Present at Two Financial Conferences in September
• [09/02] Marathon Talks Yield Tentative Agreement With North Adams Regional Hospital Nurses
• [09/02] Professor Leroux From ETH Receives the Debiopharm Life Sciences Award 2010
• [09/02] ECRI Institute, AHRQ, NIH, and Others Address the Interface Between Comparative Effectiveness and Personalized Medicine
• [09/02] AloeSafe Hand Sanitizer is Free From Toxic Chemicals
• [09/02] Cetero Research Launches Seminar Series on Accelerated Proof-of-Concept in Drug Development
• [09/02] Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports
• [09/02] Novelda AS to Exhibit Nanoscale Impulse Radar at EXPO 2010 in Shanghai, China
• [09/02] Canadian Pharmacy Intermediary SaveRxCanada.com Enhances Online Shopping System
• [09/02] Ektio Shoes Launches to Take Ankle Sprains Off the Court
• [09/02] Orexigen Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave in North America
• [09/02] Sigma Life Science Enters Genetically Modified Cell Market
• [09/01] Alere Inc. Declares Dividend on its Series B Convertible Perpetual Preferred Stock
• [09/01] HeartSine Donates AEDs to Kentucky Schools
• [09/01] Botox-maker pays $600M to resolve investigation
• [09/01] Pfizer buying FoldRx for undisclosed amount

Return to Main